Biosimilars Forum’s public letter in response to anti-biosimilars Op-Ed

29 August 2019 - Government Should Not “Throw In the Towel on Biosimilars,” They Should Act Now to Unlock Billions ...

Read more →

Dutch experience demonstrates effective benchmarking of biosimilar use in health systems

31 August 2019 - As medicines become more numerous and often more expensive, health care professionals seek new ways to understand ...

Read more →

'No jab, no pay' threat prompts an extra 174,000 children to be vaccinated in one year

1 September 2019 - A threat to cut family tax benefits for Australians who did not vaccinate their children has ...

Read more →

We need a more rational biosimilars policy

27 August 2019 - Throwing in the towel on a whole new category of medicines, just shy of a decade in, ...

Read more →

Don’t give up on biosimilars—Congress can give them a boost

25 August 2019 - Drugs grown in live cells are hard to replicate. But policy changes can help accelerate the process. ...

Read more →

Time to throw in the towel on biosimilars

21 August 2019 - A major reason drugs are even mildly affordable in the U.S. is that cheap generic copies ...

Read more →

Majority of patients not asked for consent before being switched to a biosimilar, survey finds

17 July 2019 - The preliminary survey results showed that 52% of patients received a letter from hospital about switching to ...

Read more →

Trump to order drive for improved flu vaccine

16 July 2019 - President Donald Trump is readying an executive order that would direct HHS to overhaul the development ...

Read more →

Pharmaceutical Benefits Scheme restrictions on anti‐epileptic drug prescribing promote unsafe and outdated practice

1 July 2019 - The PBS urgently needs to update anti‐epileptic drug prescribing restrictions that put patients and prescribers at ...

Read more →

Bev takes 14 pills a day. She's far from alone.

15 July 2019 - She is among the more than one-in-three Australians aged over 70 who take five or more different ...

Read more →

Biosimilars continue to exhibit market failure

11 July 2019 - From their inception, biosimilars in the U.S. have faced headwinds.  ...

Read more →

Vaccine crisis leaves Australia’s immunisation record in tatters

9 July 2019 - Thousands of Australians are dying from the flu and meningococcal because lifesaving vaccines are not being approved, ...

Read more →

Patients take outdated drugs because of PBS restrictions: UQ doctor

2 July 2019 - Patients are put at risk because the restrictions on drugs made by the Pharmaceutical Benefits Scheme ...

Read more →

Forcing patients to switch to biosimilars puts them in uncharted waters

23 June 2019 - On May 27, the B.C. government announced a policy that will forcibly switch thousands of patients, ...

Read more →

How big pharma suppresses ‘biosimilars’

23 June 2019 - Deals with insurers and pharmacy benefit managers at patient and taxpayer expense. ...

Read more →